Success in treating patients with progressive supranuclear palsy and corticobasal degeneration remains exceedingly low. This finding probably relates to the widespread distribution of the pathological changes that account for the varied and complex spectrum of clinical manifestations. Dopaminergic d
โฆ LIBER โฆ
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
โ Scribed by D. W. Dickson
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 528 KB
- Volume
- 246
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Treatment of progressive supranuclear pa
โ
Anthony E. Lang
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 230 KB
Progressive supranuclear palsy and corti
โ
Tomaso Scaravilli; Eduardo Tolosa; Isidre Ferrer
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 82 KB
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are both sporadic disorders with tau pathology. Criteria have been defined that in most instances allow for adequate diagnosis of the two disorders both clinically and neuropathologically; however, overlap is not uncommon. For
MRI of progressive supranuclear palsy, c
โ
Kimihito Arai
๐
Article
๐
2006
๐
Springer
๐
English
โ 449 KB
Cerebellar cortical tau pathology in pro
โ
Yue-Shan Piao; Shintaro Hayashi; Koichi Wakabayashi; Akiyoshi Kakita; Izumi Aida
๐
Article
๐
2002
๐
Springer-Verlag
๐
English
โ 283 KB
Clinical features differentiating patien
โ
I. Litvan; D. A. Grimes; A. E. Lang; J. Jankovic; A. McKee; M. Verny; K. Jelling
๐
Article
๐
1999
๐
Springer
๐
English
โ 41 KB
Pathologic changes of progressive supran
โ
Hideo Mori
๐
Article
๐
2006
๐
Springer
๐
English
โ 322 KB